<\/p>\n
<\/p>\n
Allied Gaming & Entertainment (NASDAQ: AGAE)<\/b> received a Nasdaq Staff Determination on May 6, 2026, after not regaining compliance with the $1.00 minimum bid price and not yet filing its 2025 Form 10-K.<\/p>\n
The company will request a hearing and plans measures, including a potential reverse stock split, to maintain its Nasdaq listing.<\/p>\n<\/div>\n
\n Loading…<\/span>\n <\/p>\n Loading translation…<\/span>\n <\/div>\n AI-generated analysis. Not financial advice.<\/p>\n<\/p><\/div>\n
<\/p>\n <\/p>\n <\/p>\n
<\/p>\n
Sector peers show mixed moves, with examples including TOON -0.47%<\/b>, KUKE +39%<\/b>, ANGH -3.61%<\/b>, and BREA -12.32%<\/b>. Only TOON<\/b> appeared on the momentum scanner, and overall activity does not indicate a unified sector move, supporting this as stock-specific listing and compliance risk.<\/p>\n<\/p><\/div><\/div>\n<\/div>\n <\/p>\n
<\/p>\n
<\/p>\n
<\/p>\n
<\/p>\n
\n <\/thead>\n
<\/p>\n
<\/p>\n
<\/p>\n
<\/p>\n
<\/p>\n
<\/p>\n
<\/p>\n
<\/p>\n
<\/p>\n
<\/p>\n
<\/p>\n
<\/p>\n
<\/p>\n
<\/p>\n
<\/p>\n
<\/p>\n
Recent news has often been followed by declines, including -9.92%<\/b> after the AI rebranding plan and -14.97%<\/b> after the short\u2011selling review. Even balance-sheet and policy updates saw slight weakness, suggesting investors have been selling into both strategic and regulatory headlines.<\/p>\n<\/p><\/div><\/div>\n Over the past month, AGAE has issued several material updates. On Apr 20<\/b>, it detailed an internal reference floor of US$2.00<\/b> per share backed by US$98.01M<\/b> in assets, yet shares slipped slightly. A Nasdaq deficiency letter<\/b> on the delayed 2025 Form 10-K and a statement on unusual short\u2011selling activity each drew further declines. The May 4<\/b> AI rebranding and supercomputing center plan, with up to US$300M<\/b> in proposed financing, also met with selling, framing today\u2019s Nasdaq stock\u2011price notice within a pattern of skepticism toward recent corporate actions.<\/p>\n<\/p><\/div><\/div><\/div>\n<\/div>\n <\/p>\n <\/p>\n <\/p>\n
<\/p>\n
<\/p>\n “including a reverse stock split and other relevant measures to naturally raise the stock price”<\/p>\n A reverse stock split is when a company reduces the number of its shares outstanding, making each share more valuable. For example, if you own 100 shares worth $1 each, a 1-for-10 reverse split would turn your 100 shares into 10 shares worth $10 each. Companies often do this to boost their stock price and appear more stable to investors.<\/p>\n<\/p><\/div>\n
<\/p>\n “the contents of which were disclosed in the Company\u2019s Form 8-K filed on May 11, 2026”<\/p>\n A Form 8-K is a report that companies file with the government to share important news quickly, such as changes in leadership, major business deals, or financial updates. It matters because it helps investors stay informed about significant events that could affect the company’s value or stock price.<\/p>\n<\/p><\/div>\n
<\/p>\n “has not yet filed its Annual Report on Form 10-K for the year ended December 31, 2025”<\/p>\n An annual report on Form 10\u2011K is a required, comprehensive filing that publicly traded companies give to regulators and investors summarizing their business, results of operations, detailed financial statements reviewed by independent auditors, material risks, legal issues and management\u2019s discussion of performance. Investors use it like a company\u2019s year\u2011end report card and medical checkup: it reveals how the business made money, where it is vulnerable, and the facts needed to compare value, judge risk and make informed investment decisions.<\/p>\n<\/p><\/div>\n
<\/p>\n <\/p>\n AI-generated analysis. Not financial advice.<\/p>\n<\/p><\/div><\/div>\n<\/div>\n
Positive<\/h3>\n
\n
<\/p>\n
\n
<\/p>\n
\n
<\/p>\n
\n
\n <\/ul>\n<\/p><\/div>\nNegative<\/h3>\n
\n
<\/p>\n
\n
<\/p>\n
\n
<\/p>\n
\n
\n <\/ul>\n<\/p><\/div><\/div>\n
\n<\/p>\n
\n Nasdaq minimum bid<\/span>
\n $1.00<\/span>
\n
\n Required stock price to maintain listing under Nasdaq rules<\/span>
\n
\n <\/p>\n
\n Nasdaq notice date<\/span>
\n May 6, 2026<\/span>
\n
\n Date Nasdaq Staff Determination letter was received<\/span>
\n
\n <\/p>\n
\n Hearing request deadline<\/span>
\n May 13, 2026<\/span>
\n
\n Date by which the company will request a hearing<\/span>
\n
\n <\/p>\n
\n Stay period<\/span>
\n 15 days<\/span>
\n
\n Automatic stay of suspension after hearing request<\/span>
\n
\n <\/p>\n
\n 10-K year-end<\/span>
\n December 31, 2025<\/span>
\n
\n Fiscal year for the delayed Annual Report on Form 10-K<\/span>
\n
\n <\/p>\n<\/p><\/div><\/div>\n<\/div>\n
\n $0.4500<\/span>
\n Last Close<\/span>
\n <\/p>\n
\n Volume<\/span>
\n Volume 736,224<\/b> is about 0.02x<\/b> the 20-day average of 38,174,888<\/b>, indicating muted trading ahead of this listing notice.<\/span>
\n
\n low<\/span>
\n
\n <\/p>\n
\n Technical<\/span>
\n Shares at $0.45<\/b> are trading below the $0.64<\/b> 200-day moving average, reflecting a sustained downtrend into the Nasdaq price-deficiency update.<\/span>
\n <\/p>\n<\/p><\/div><\/div>\n<\/div>\n
<\/p>\n
<\/p>\n
<\/p>\n
Date<\/th>\n Event<\/th>\n Sentiment<\/th>\n Move<\/th>\n Catalyst<\/th>\n
\n <\/tr>\n
\n
<\/p>\n
<\/p>\n May 04<\/td>\n
\n
\n AI pivot & financing<\/a>
\n
\n <\/td>\n
\n Positive<\/span>
\n <\/td>\n
\n
<\/p>\n
\n -9.9%
\n <\/td>\n
\n
\n
\n
\n Announced AI-focused rebranding and up to US$300M convertible note financing plan.
\n <\/td>\n
\n <\/tr>\n
\n
<\/p>\n
<\/p>\n Apr 27<\/td>\n
\n
\n Shareholder no-sale pledge<\/a>
\n
\n <\/td>\n
\n Negative<\/span>
\n <\/td>\n
\n
<\/p>\n
\n -9.1%
\n <\/td>\n
\n
\n Major holder\u2019s non-binding no-sale commitment highlighted lack of enforceable lock-up.
\n <\/td>\n
\n <\/tr>\n
\n
<\/p>\n
<\/p>\n Apr 21<\/td>\n
\n
\n Nasdaq filing deficiency<\/a>
\n
\n <\/td>\n
\n Negative<\/span>
\n <\/td>\n
\n
<\/p>\n
\n -4.7%
\n <\/td>\n
\n
\n Nasdaq letter over delayed Form 10-K and timetable for compliance plan submission.
\n <\/td>\n
\n <\/tr>\n
\n
<\/p>\n
<\/p>\n Apr 21<\/td>\n
\n
\n Short-selling review<\/a>
\n
\n <\/td>\n
\n Negative<\/span>
\n <\/td>\n
\n
<\/p>\n
\n -15.0%
\n <\/td>\n
\n
\n Board formed special committee to address volatility and elevated short\u2011selling signals.
\n <\/td>\n
\n <\/tr>\n
\n
<\/p>\n
<\/p>\n Apr 20<\/td>\n
\n
\n M&A pricing policy<\/a>
\n
\n <\/td>\n
\n Positive<\/span>
\n <\/td>\n
\n
<\/p>\n
\n -0.3%
\n <\/td>\n
\n
\n
\n
\n Updated internal floor for future M&A share issuances and disclosed asset metrics.
\n <\/td>\n
\n <\/tr>\n
\n
\n <\/tbody>\n
\n <\/table>\n<\/p><\/div>\n
\n This announcement details a Nasdaq Staff Determination over AGAE\u2019s share price remaining below $1.00<\/b> and the delayed 2025 Form 10-K, along with plans to request a hearing and consider a reverse stock split. In recent months, investors have reacted cautiously to governance, litigation, and strategy updates. Going forward, the hearing outcome, timing of the 2025 Form 10-K filing, and any concrete corporate actions to restore listing compliance will be important to monitor.
\n <\/p>\n<\/p><\/div>\n<\/div>\n
\n reverse stock split<\/span>
\n
\n financial<\/span>
\n
\n <\/summary>\n
\n <\/details>\n
\n form 8-k<\/span>
\n
\n regulatory<\/span>
\n
\n <\/summary>\n
\n <\/details>\n
\n annual report on form 10-k<\/span>
\n
\n regulatory<\/span>
\n
\n <\/summary>\n
\n <\/details>\n<\/p><\/div><\/div>\n<\/div>\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n